Elexacaftor/tezacaftor/ivacaftor is an approved treatment for children and adults with cystic fibrosis. Development of docking stations on the respiratory tract is ...
The paper: S. Shenoy et al., "β-Arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor," J Biol Chem, 281:1261-73, 2006. (Cited in 50 papers) The finding: In 2005, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback